Financials Aurora Spine Corporation

Equities

ASG

CA05206X1087

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. 15:59:47 2024-05-10 EDT 5-day change 1st Jan Change
0.265 CAD 0.00% Intraday chart for Aurora Spine Corporation +6.00% -33.75%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 12.47 10.01 17.4 18.21 22.39 23.19
Enterprise Value (EV) 1 13.63 12.1 18.16 17.58 24.94 26.07
P/E ratio -170 x -7.98 x -73.9 x -6.79 x -14.9 x -12.7 x
Yield - - - - - -
Capitalization / Revenue 1.44 x 0.9 x 2.01 x 1.73 x 1.51 x 1.6 x
EV / Revenue 1.57 x 1.09 x 2.1 x 1.67 x 1.68 x 1.8 x
EV / EBITDA 15.6 x -15 x -26.5 x -8.56 x -33.6 x -34.2 x
EV / FCF 675 x 302 x -18.3 x -7.17 x -11.9 x -27.1 x
FCF Yield 0.15% 0.33% -5.46% -14% -8.4% -3.7%
Price to Book 4.31 x 5.66 x 5.31 x 3.27 x 5.21 x 4.41 x
Nbr of stocks (in thousands) 45,434 46,478 55,410 66,731 66,731 76,867
Reference price 2 0.2746 0.2154 0.3140 0.2729 0.3356 0.3017
Announcement Date 19-04-26 20-06-04 21-04-30 22-04-29 23-04-28 24-04-30
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 8.682 11.15 8.646 10.54 14.88 14.52
EBITDA 1 0.872 -0.8052 -0.6862 -2.054 -0.7412 -0.763
EBIT 1 0.0914 -1.079 -1.163 -2.55 -1.343 -1.495
Operating Margin 1.05% -9.68% -13.46% -24.19% -9.03% -10.3%
Earnings before Tax (EBT) 1 -0.0682 -1.254 -0.2321 -2.359 -1.501 -1.681
Net income 1 -0.0682 -1.254 -0.2321 -2.359 -1.501 -1.681
Net margin -0.79% -11.25% -2.68% -22.37% -10.09% -11.57%
EPS 2 -0.001617 -0.0270 -0.004247 -0.0402 -0.0225 -0.0238
Free Cash Flow 1 0.0202 0.0401 -0.9918 -2.453 -2.096 -0.9637
FCF margin 0.23% 0.36% -11.47% -23.26% -14.09% -6.64%
FCF Conversion (EBITDA) 2.32% - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-04-26 20-06-04 21-04-30 22-04-29 23-04-28 24-04-30
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1.16 2.09 0.76 - 2.55 2.88
Net Cash position 1 - - - 0.63 - -
Leverage (Debt/EBITDA) 1.33 x -2.599 x -1.103 x - -3.437 x -3.773 x
Free Cash Flow 1 0.02 0.04 -0.99 -2.45 -2.1 -0.96
ROE (net income / shareholders' equity) -2.96% -53.1% -9.19% -53.3% -30.4% -35%
ROA (Net income/ Total Assets) 0.94% -9.98% -10.5% -18% -8.12% -8.46%
Assets 1 -7.239 12.56 2.207 13.11 18.5 19.88
Book Value Per Share 2 0.0600 0.0400 0.0600 0.0800 0.0600 0.0700
Cash Flow per Share 2 0.0200 0.0100 0.0300 0.0500 0.0100 0.0100
Capex 1 0.29 0.29 0.51 0.72 0.77 0.48
Capex / Sales 3.37% 2.57% 5.9% 6.83% 5.18% 3.3%
Announcement Date 19-04-26 20-06-04 21-04-30 22-04-29 23-04-28 24-04-30
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ASG Stock
  4. Financials Aurora Spine Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW